D2 - Pharmacoeconomics teaching and research in pharmacy schools: Too little, too late?

Auditorium 1

Organised by the FIP Academic Pharmacy Section in collaboration with FIP’s Social and Administrative Pharmacy Section & SIG on Pharmacy Practice Research & FIPEd

Chair

Arijana Meštrović:, Pharma Expert, Croatia

Introduction

As pharmacy educators and practitioners around the world embrace the fast-moving healthcare provision landscape and the introduction of advanced technologies, they need to develop the skills required not only to understand these technologies but also assess their value. At a time where healthcare budgets are limited on the global level, not every new technology can be funded or used on a large scale. Enabling pharmacists and pharmaceutical policy makers to make rational decisions about the allocation of these limited resources is critically important for the sustainability of service provision. This is only possible through education and training in areas of relevance, including pharmacoeconomics (PE) and health technology assessment. Unfortunately, there has been limited focus in pharmacy schools on teaching pharmacoeconomics, not only in the developing world but also in some of the major economies such as the UK. The integration of PE teaching and research in pharmacy undergraduate and postgraduate curricula has been progressing at snail’s pace.

In this first presentation, we will describe the current status of PE education in pharmacy schools across the world focusing on USA, Europe, the Middle East and South East Asia. Audience participation will also be sought through polling to allow sharing experiences relating to the status of pharmacoeconomics education in their countries, pharmacy schools and/or its application and use in decision making in their work settings. 

We will then follow by presenting the case for teaching PE to pharmacy students both in the undergraduate and postgraduate stages as well as for continuous professional development purposes. The opportunities that exist for pharmacy graduates and their employers from developing these skills will also be outlined and the career pathways for pharmacists who specialize in this area will be described. 

The final presentation will then discuss the challenges faced when introducing such interdisciplinary branch of knowledge into the science-focused pharmacy curricula and present case studies for overcoming these barriers. Participants will be introduced to a range of resources available through different organizations to support the introduction of PE in their pharmacy schools’ programs. They will be invited to sign up to a “mentoring scheme” either as mentors or mentees, with the opportunity given for “pairing” mentees who want to embark on starting a program of teaching or research in PE with mentors who managed to successfully integrate PE in their pharmacy schools’ curricula at different levels.

 

Programme

  1. Current status of pharmacoeconomics teaching in pharmacy schools: An international overview
    Zaheer-Ud-Din Babar, University of Huddersfield, UK
  2. Pharmacoeconomics teaching and research: Why now?
    Dalia Dawoud, Cairo University, Egypt
  3. Integrating pharmacoeconomics in pharmacy schools’ curricula: Overcoming the challenges
    Timothy Chen, The University of Sydney, Australia

Learning Objectives

At the end of this session, participants will be able to:

  1. Endorse pharmacoeconomics as an important branch of pharmaceutical knowledge
  2. Advocate for the introduction of pharmacoeconomics into pharmacy schools’ curricula
  3. Justify the need for pharmacists to develop skills in pharmacoeconomics and apply them in making decisions about the adoption of new technologies and medicines

Type of session: Application-based